Xenon Pharmaceuticals Growth Metrics (2013-2026) | XENE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	-0.10M	-0.00M	-0.04M	0.02M	-0.46M	-2.87M
EBITDA Margin Growth (3y) (Quarter)						-2.86M										-0.08M
EBITDA Margin Growth (5y) (Quarter)	0.05M	0.16M	0.08M	4.97M	4.70M	-2.56M										-0.09M
EBITDA Margin (QoQ) (Quarter)	-0.06M	0.08M	-0.05M	0.05M	-0.55M	-2.32M
EBIT Margin Growth (1y) (Quarter)	-0.10M	-0.00M	-0.04M	0.02M	-0.46M	-2.87M
EBIT Margin Growth (3y) (Quarter)						-2.86M										-0.08M
EBIT Margin Growth (5y) (Quarter)	0.05M	0.16M	0.08M	4.97M	4.70M	-2.56M										-0.09M
EBIT Margin (QoQ) (Quarter)	-0.06M	0.08M	-0.05M	0.05M	-0.55M	-2.32M
EBT Margin Growth (1y) (Quarter)	-0.10M	-0.01M	-0.04M	0.01M	-0.48M	-2.84M
EBT Margin Growth (3y) (Quarter)						-2.83M										-0.06M
EBT Margin Growth (5y) (Quarter)	0.05M	0.16M	0.19M	4.88M	4.61M	-2.54M										-0.08M
EBT Margin (QoQ) (Quarter)	-0.06M	0.08M	-0.05M	0.04M	-0.56M	-2.28M
Enterprise Value Growth (1y) (Quarter)	-28.49%	-30.74%	-211.74%	-95.83%	-202.56%	-155.66%	-7.31%	2.03%	31.54%	17.47%	-7.77%	-32.74%	-33.72%	-24.18%	1.75%	21.44%	-35.41%	-39.60%	-49.27%	-99.18%
Enterprise Value Growth (3y) (Quarter)	-60.28%	-25.22%	-66.61%	-69.52%	-97.83%	-88.95%	-61.20%	-31.90%	-38.58%	-40.25%	-53.33%	-36.56%	-40.43%	-37.86%	-4.35%	-0.72%	-7.42%	-12.68%	-16.48%	-27.59%
Enterprise Value Growth (5y) (Quarter)	-38.71%	-29.14%	-53.79%	-56.11%	-72.44%	-70.90%	-68.44%	-71.93%	-53.52%	-32.88%	-39.84%	-44.66%	-47.95%	-47.21%	-34.70%	-19.07%	-36.96%	-36.75%	-39.52%	-31.85%
Enterprise Value (QoQ) (Quarter)	5.16%	4.18%	-121.04%	2.51%	-46.53%	19.04%	7.22%	10.99%	-2.38%	2.40%	-21.15%	-9.64%	-3.14%	9.36%	4.15%	12.33%	-77.76%	6.55%	-2.49%	-16.99%
FCF Margin Growth (1y) (Quarter)	-0.05M	-518.00	-0.03M	0.03M	-0.26M	-2.31M
FCF Margin Growth (3y) (Quarter)						-2.31M										-0.06M
FCF Margin Growth (5y) (Quarter)	0.07M	0.09M	0.07M	4.10M	4.28M	-2.01M										-0.06M
FCF Margin (QoQ) (Quarter)	-0.01M	0.04M	-0.04M	0.04M	-0.30M	-2.01M
Interest Coverage Ratio Growth (1y) (Quarter)	-5,535.47%	-126.44%		94.63%	22.09%	28.97%	-27.27%	-1,705.78%	19.74%	77.42%	14.02%	81.67%	74.89%	-51.62%	-36.86%	-50.86%	-1,407.86%	-56.39%	-39.39%	-81.79%
Interest Coverage Ratio Growth (3y) (Quarter)	-0.48%	-9.30%	-99.32%	57.89%	-67.91%	-48.25%	-66.63%	-57.14%	-227.85%	28.66%		43.80%	46.05%	37.58%	-14.41%	-70.91%	-44.85%	18.80%	-17.93%	20.49%
Interest Coverage Ratio Growth (5y) (Quarter)			-150.70%				-24.95%	11.26%	8.70%	26.86%	-53.34%	24.39%	0.93%	-2.21%	-40.34%	-1.41%	-166.11%	2.95%		13.41%
Interest Coverage Ratio (QoQ) (Quarter)	-38.18%	29.09%	-343.54%	98.77%	-1,906.64%	35.35%	-694.71%	82.48%	10.81%	81.82%	-2,926.41%	96.27%	-22.22%	-9.80%	-2,631.67%	95.88%	-1,121.59%	88.61%	-2,334.78%	94.63%
Net Margin Growth (1y) (Quarter)	-0.10M	-0.01M	-0.04M	0.01M	-0.48M	-2.80M
Net Margin Growth (3y) (Quarter)						-2.79M										-0.06M
Net Margin Growth (5y) (Quarter)	0.05M	0.16M	0.19M	4.68M	4.61M	-2.49M										-0.08M
Net Margin (QoQ) (Quarter)	-0.06M	0.08M	-0.05M	0.05M	-0.56M	-2.23M
Operating Margin Growth (1y) (Quarter)	-0.10M	-0.00M	-0.04M	0.02M	-0.46M	-2.87M
Operating Margin Growth (3y) (Quarter)						-2.86M										-0.08M
Operating Margin Growth (5y) (Quarter)	0.05M	0.16M	0.08M	4.97M	4.70M	-2.56M										-0.09M
Operating Margin (QoQ) (Quarter)	-0.06M	0.08M	-0.05M	0.05M	-0.55M	-2.32M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	-844.00	-0.00M	-211.00	280.00	968.00	0.00M	216.00	-809.00	-0.00M	-0.00M	-967.00	-185.00	31.00	41.00	-867.00	-0.00M	-0.00M	-0.00M	-0.00M	-287.00
Return on Capital Employed Growth (3y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	467.00	-0.00M	-0.00M	-962.00	-715.00	-444.00	-464.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed Growth (5y) (Quarter)	498.00	0.00M	0.00M				0.01M	0.01M	0.00M	906.00	403.00	0.00M	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed (QoQ) (Quarter)	-564.00	-328.00	657.00	514.00	124.00	-109.00	-314.00	-511.00	-510.00	-357.00	411.00	271.00	-293.00	-348.00	-497.00	-392.00	-741.00	-946.00	-793.00	0.00M
Return on Invested Capital Growth (1y) (Quarter)
Return on Invested Capital (QoQ) (Quarter)
Return on Sales Growth (1y) (Quarter)	-10.00	-1.00	-5.00	1.00	-48.00	-280.00	-6.00									274.00	0.00M
Return on Sales Growth (3y) (Quarter)						-279.00	-13.00					-279.00	-0.00M			-6.00	21.00	241.00	-34.00
Return on Sales Growth (5y) (Quarter)	5.00	16.00	19.00	488.00	461.00	-249.00	494.00									-8.00	-37.00	-39.00	-45.00
Return on Sales (QoQ) (Quarter)	-6.00	8.00	-5.00	5.00	-56.00	-223.00	268.00						-0.00M				-28.00	-4.00	-7.00

Research Tools

Developers

Xenon Pharmaceuticals Growth Metrics (2013-2026) | XENE

Research Tools

Developers

Xenon Pharmaceuticals Growth Metrics (2013-2026) | XENE

Create an account

Sign In

Reset Password